These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8628496)

  • 1. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.
    McGuire D; Garrison L; Armon C; Barohn R; Bryan W; Miller R; Parry G; Petajan J; Ross M
    Neurology; 1996 May; 46(5):1442-4. PubMed ID: 8628496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group.
    McGuire D; Garrison L; Armon C; Barohn RJ; Bryan WW; Miller R; Parry GJ; Petajan JH; Ross MA
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S18-22. PubMed ID: 9419049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam.
    Shields RK; Ruhland JL; Ross MA; Saehler MM; Smith KB; Heffner ML
    Arch Phys Med Rehabil; 1998 Jul; 79(7):855-62. PubMed ID: 9685105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies.
    Damiano AM; Patrick DL; Guzman GI; Gawel MJ; Gelinas DF; Natter HM; Ingalls KK
    Med Care; 1999 Jan; 37(1):15-26. PubMed ID: 10413388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis.
    Andres PL; Finison LJ; Conlon T; Thibodeau LM; Munsat TL
    Neurology; 1988 Mar; 38(3):405-8. PubMed ID: 3347344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative motor assessment in amyotrophic lateral sclerosis.
    Andres PL; Hedlund W; Finison L; Conlon T; Felmus M; Munsat TL
    Neurology; 1986 Jul; 36(7):937-41. PubMed ID: 3714055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation restrictions in ambulatory amyotrophic lateral sclerosis patients: Physical and psychological factors.
    Van Groenestijn AC; Schröder CD; Kruitwagen-Van Reenen ET; Van Den Berg LH; Visser-Meily JMA
    Muscle Nerve; 2017 Nov; 56(5):912-918. PubMed ID: 28073181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in the evaluation of isometric strength (TQNE) data in ALS.
    Conradi S; Ronnevi LO
    J Neurol Sci; 1996 Aug; 139 Suppl():60-3. PubMed ID: 8899660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.
    Pascuzzi RM; Shefner J; Chappell AS; Bjerke JS; Tamura R; Chaudhry V; Clawson L; Haas L; Rothstein JD
    Amyotroph Lateral Scler; 2010 May; 11(3):266-71. PubMed ID: 19961264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in ALS depends on factors other than strength and physical function.
    Simmons Z; Bremer BA; Robbins RA; Walsh SM; Fischer S
    Neurology; 2000 Aug; 55(3):388-92. PubMed ID: 10932273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.
    Pradas J; Finison L; Andres PL; Thornell B; Hollander D; Munsat TL
    Neurology; 1993 Apr; 43(4):751-5. PubMed ID: 8469335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement among three quality of life measures in patients with ALS.
    Smith PS; Crossley B; Greenberg J; Wilder C; Carroll B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Sep; 1(4):269-75. PubMed ID: 11465020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis.
    Neudert C; Wasner M; Borasio GD
    J Palliat Med; 2004 Aug; 7(4):551-7. PubMed ID: 15353099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with ALS show highly correlated progression rates in left and right limb muscles.
    Rushton DJ; Andres PL; Allred P; Baloh RH; Svendsen CN
    Neurology; 2017 Jul; 89(2):196-206. PubMed ID: 28600459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study.
    Jawdat O; Rucker J; Nakano T; Takeno K; Statland J; Pasnoor M; Dimachkie MM; Sabus C; Badawi Y; Hunt SL; Tomioka NH; Gunewardena S; Bloomer C; Wilkins HM; Herbelin L; Barohn RJ; Nishimune H
    Sci Rep; 2024 Sep; 14(1):21729. PubMed ID: 39289471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing health status quality of life in ALS: comparison of the SIP/ALS-19 with the ALS Functional Rating Scale and the Short Form-12 Health Survey. ALS C.A.R.E. Study Group. Clinical Assessement, Research, and Education.
    Bromberg MB; Anderson F; Davidson M; Miller RG
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2(1):31-7. PubMed ID: 11465931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of instruments addressing quality of life in patients with ALS and their caregivers.
    Bromberg MB; Forshew DA
    Neurology; 2002 Jan; 58(2):320-2. PubMed ID: 11805269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.
    Neudert C; Wasner M; Borasio GD
    J Neurol Sci; 2001 Oct; 191(1-2):103-9. PubMed ID: 11676999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.
    Prell T; Gaur N; Stubendorff B; Rödiger A; Witte OW; Grosskreutz J
    J Neurol Sci; 2019 Feb; 397():92-95. PubMed ID: 30597420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.